Alright, so this blog post is a bit long, but I loved this couple,
and his story is pretty typical for people dealing with chronic heart failure,
so I wanted to do it justice… so sorry, not sorry!
The physician I
worked with often provided cardiology care for couples, scheduling their appointments
togethers. One such couple had been following for over 20 years and were some
of my favorite patients. The husband had 4 chamber dilated cardiomyopathy. Basically
all 4 chambers of his heart were wider than they should be, which only increased
the workload on his heart and decreased his overall cardiac efficiency. At this
point, his medications were hardly helping and because of the dilation he had
severe valvular regurgitation. Meaning the leaflets on the mitral and tricuspid
valves could not close all the way when the ventricles contracted as the
leaflets could not reach each other, allowing a significant amount of blood that
was supposed to be being pumped to the rest of his body and his lungs, to flow
back into the atria. As you can imagine (BL 618 people I’m looking at you) this
reduced his cardiac output, leading to significant shortness of breath, peripheral
edema, ascites (fluid collection in the abdomen), and malaise. Basically, he
felt like crap. He was not a great candidate for an open-heart valve
replacement surgery given his age, comorbidities, and the fact that surgery would
not cure his underlying heart failure. We were trying to figure out what we
could do to help ease his symptoms and make him more comfortable. He was
already coming to the hospital for paracentesis every two weeks to remove the
fluid accumulating in his abdomen as his organs struggled to keep up. We were
running out of conventional treatment options and our patient was miserable and
in poor spirits.
The
physician mentioned a MitraClip (Figure 1 and 2) could be an option for
alleviating his symptoms. The MitraClip, is basically a “staple” that is meant
to hold the leaflets of valves together in cases of severe mitral valvular
regurgitation. The MitraClip implant is a transcatheter procedure, meaning it
is done via a catheter through the femoral artery eliminating the need for open-heart
surgery (which is a very exciting advancement for valve procedures!) Originally,
this device was approved only for use in patients whose mitral regurgitation
(MR) was due to structural issues with the valves, such as stenosis (stiffening
of the valve leaflets). Recently, however, the FDA approved MitraClips to be
used on valves that were “leaky” due to heart failure rather than just a
structural issue, due to the significantly improved quality of life seen in
patients involved in the clinical trial.
Figure 1.
Now as exciting as this new
indication for the use of the MitraClip is, it does not cure the underlying
heart failure. After the physician mentioned this, we had an interesting
conversation on ethics as we wondered if this procedure would only prolong the
inevitable (I know, sounds super morbid but that’s the reality) which brings in
the question of non-malfeasance (ethics trigger word!), or if this could be the
best option for the patient and would be acting with beneficence to help his
symptoms. Regardless of what our opinion was, it was important that our patient
maintain his autonomy and make the decision for himself. We therefore decided
to present him with this as a treatment option but provide education on what
the procedure entailed and inform him that it may work, or it may not and he
could undergo a procedure with no resolution in his symptoms. Thus ensued one
of the most emotional and honest conversations I have ever been a part of with
a patient as we explained his condition was only worsening, he likely did not
have much longer to live, and there was no promise this procedure would improve
his symptoms or prolong his life…but it was a possibility and he deserved to
hear all his options. Ultimately, he wanted the procedure.
We sent our patient to a structural
cardiothoracic surgeon who thought he was a good candidate and ultimately ended
up placing two MitraClips in his Mitral Valve and one in his Tricuspid Valve!
That’s a lot of clips! For reference, normally patients only receive one or two
clips and in only one valve.
His symptoms improved! During his
next office visit, we immediately noticed his spirits were lifted, his color
was better, his breathing had improved, he seemed to have stabilized! This went
on for about 6 months, but eventually his symptoms worsened. This procedure had
improved his quality of life for a time, but ultimately, they did not cure his
underlying heart failure and overall reason his valves had “failed” in the
first place. He passed away soon after his symptoms returned. When we met with
his wife later (as she was also a patient of this physician), she mentioned he had
been happy for the extra time and the brief reprieve in his symptoms. I don’t
believe there is a right or wrong medical decision that could have been made in
this case, but I do believe patient education and presenting all his options
was a very important ethical decision.
https://www.abbott.com/corpnewsroom/products-and-innovation/mitraclip-now-helps-many-more-with-smr.html?CID=PS_BIS_HH_GA_287&gclid=Cj0KCQiAys2MBhDOARIsAFf1D1dXs87ZsgoYRF8EUpeiuN7X9ULsJ_SC271mkjd7HWslGLcT7rkmXaYaAmnBEALw_wcB&gclsrc=aw.ds
I am so glad that you were able to make a blog concerning your own experiences, this helps the perspective for many students about what "the real world" looks like and apply it to class.
ReplyDeleteThe ethics of this is really challenging, because its true you always have to consider if your treatment will improve their quality of life or just prolong it. I am very happy you were able to see this thought process in action because implants/surgery should never be taken lightly.
I am so thrilled that his symptoms improved!
What other ways do you think we should apply this to as practicing medical professionals? I think this could apply to any treatment really, before you decide to do anything to anyone there is a risk benefit scale you have to evaluate.
Amber, thanks for sharing your experiences and perspectives on this difficult case. When I saw that your blogpost was about MitraClips, I got a little excited because one of my blog posts is about Dr. Oz, and I remember reading that he was one of the inventors of the MitraClip, specifically the catheter part.
ReplyDeleteAfter reading your post, I became more interested in learning about MitraClips because I have bicuspid aortic valve. As you know from your experiences in the cardiology clinic, I am at risk in the future for valve regurgitation. Although your case study talks about mitral and tricuspid valves, I was curious if MitraClips are being used for aortic valves, or even for bicuspid aortic valves. I couldn’t find anything on aortic valves, but it seems that MitraClips are effective and safe in conjunction with TAVR (Gandhi et al., 2017). Hopefully research continues on MitraClip efficacy as it seems to be a promising therapeutic for patients with heart disease.
Gandhi, S., Natarajan, M. K., Chu, V., Dokainish, H., Mehta, S., & Velianou, J. L. (2017). MitraClip and Transcatheter Aortic Valve Replacement in a Patient With Recurrent Heart Failure. Circulation. Cardiovascular interventions, 10(9), e005312. https://doi.org/10.1161/CIRCINTERVENTIONS.117.005312